title: Combining evidence for access to and benefits from antiretroviral treatment to inform planning.
authors.affiliation: Harvard School of Public Health, Boston, MA, USA. marlink@hsph.harvard.edu
authors.forename: Richard
authors.initials: R
authors.lastname: Marlink
authors.forename: Steven
authors.initials: S
authors.lastname: Forsythe
authors.forename: Stefano M
authors.initials: SM
authors.lastname: Bertozzi
authors.forename: Debbie
authors.initials: D
authors.lastname: Muirhead
authors.forename: Marionette
authors.initials: M
authors.lastname: Holmes
authors.forename: Jeffrey
authors.initials: J
authors.lastname: Sturchio
mesh_terms: D044966:Anti-Retroviral Agents / Q000191:economics / Q000600:supply & distribution* / Q000627:therapeutic use; D003362:Cost-Benefit Analysis; D003906:Developing Countries; D015658:HIV Infections / Q000188:drug therapy* / Q000191:economics; D006285:Health Planning / Q000379:methods*; D006801:Humans; D019057:Quality-Adjusted Life Years
chemical_list: D044966:Anti-Retroviral Agents